Literature DB >> 34014468

Role of ZBTB7A zinc finger in tumorigenesis and metastasis.

Atul Kumar Singh1, Shiv Verma2,3, Prem Prakash Kushwaha1, Kumari Sunita Prajapati1, Mohd Shuaib1, Shashank Kumar4, Sanjay Gupta5,6,7,8,9.   

Abstract

The zinc finger and BTB (broad-complex, tramtrack and bric a brac) domain containing protein 7A (ZBTB7A) is a pleiotropic transcription factor that plays an important role in various stages of cell proliferation, differentiation, and other developmental processes. ZBTB7A is a member of the POK family that directly and specifically binds to short DNA recognition sites located near their target genes thereby acting as transcriptional activator or repressor. ZBTB7A overexpression has been associated with tumorigenesis and metastasis in various human cancer types, including breast, prostate, lung, ovarian, and colon cancer. However in some instances downregulation of ZBTB7A results in tumor progression, suggesting its role as a tumor suppressor. ZBTB7A is involved with complicated regulatory networks which include protein-protein and protein-nucleic acid interactions. ZBTB7A involvement in cancer progression and metastasis is perhaps enabled through the regulation of various signaling pathways depending on the type and genetic context of cancer. The association of ZBTB7A with other proteins affects cancer aggressiveness, therapeutic resistance and clinical outcome. This review focuses on the involvement of ZBTB7A in various signaling pathways and its role in cancer progression. We will also review the literature on ZBTB7A and cancer which could be potentially explored for its therapeutic implications.

Entities:  

Keywords:  BTB domain; Human cancer; Therapeutic resistance; Transcription factor; ZBTB7A; Zinc finger

Mesh:

Substances:

Year:  2021        PMID: 34014468     DOI: 10.1007/s11033-021-06405-x

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  74 in total

Review 1.  ZBTB7A links tumor metabolism to myeloid differentiation.

Authors:  Enric Redondo Monte; Paul Kerbs; Philipp A Greif
Journal:  Exp Hematol       Date:  2020-06-07       Impact factor: 3.084

2.  Evaluation of transforming growth factor-β1 suppress Pokemon/epithelial-mesenchymal transition expression in human bladder cancer cells.

Authors:  Wei Li; Amritha Kidiyoor; Yangyang Hu; Changcheng Guo; Min Liu; Xudong Yao; Yuanyuan Zhang; Bo Peng; Junhua Zheng
Journal:  Tumour Biol       Date:  2014-10-22

3.  Tumor-targeted inhibition by a novel strategy - mimoretrovirus expressing siRNA targeting the Pokemon gene.

Authors:  Zhiqiang Tian; Huaizhi Wang; Zhengcai Jia; Jinglei Shi; Jun Tang; Liwei Mao; Hongli Liu; Yijing Deng; Yangdong He; Zhihua Ruan; Jintao Li; Yuzhang Wu; Bing Ni
Journal:  Curr Cancer Drug Targets       Date:  2010-12       Impact factor: 3.428

4.  Expression analysis of Akirin-2, NFκB-p65 and β-catenin proteins in imatinib resistance of chronic myeloid leukemia.

Authors:  Arzu Zeynep Karabay; Asli Koc; Tulin Ozkan; Yalda Hekmatshoar; Buket Altinok Gunes; Asuman Sunguroglu; Zeliha Buyukbingol; Arzu Atalay; Fugen Aktan
Journal:  Hematology       Date:  2018-06-26       Impact factor: 2.269

Review 5.  Emerging role of ZBTB7A as an oncogenic driver and transcriptional repressor.

Authors:  Sanjay Gupta; Atul Kumar Singh; Kumari Sunita Prajapati; Prem Prakash Kushwaha; Mohd Shuaib; Shashank Kumar
Journal:  Cancer Lett       Date:  2020-04-26       Impact factor: 8.679

6.  POZ domain transcription factor, FBI-1, represses transcription of ADH5/FDH by interacting with the zinc finger and interfering with DNA binding activity of Sp1.

Authors:  Dong-Kee Lee; Dongchul Suh; Howard J Edenberg; Man-Wook Hur
Journal:  J Biol Chem       Date:  2002-05-09       Impact factor: 5.157

7.  The effect of Pokemon on bladder cancer epithelial-mesenchymal transition.

Authors:  Changcheng Guo; Kai Zhu; Wei Sun; Bin Yang; Wenyu Gu; Jun Luo; Bo Peng; Junhua Zheng
Journal:  Biochem Biophys Res Commun       Date:  2014-01-03       Impact factor: 3.575

8.  ZBTB7A promotes migration, invasion and metastasis of human breast cancer cells through NF-κB-induced epithelial-mesenchymal transition in vitro and in vivo.

Authors:  Anyun Mao; Maojian Chen; Qinghong Qin; Zhijie Liang; Wei Jiang; Weiping Yang; Changyuan Wei
Journal:  J Biochem       Date:  2019-12-01       Impact factor: 3.387

9.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.

Authors:  Ethan Cerami; Jianjiong Gao; Ugur Dogrusoz; Benjamin E Gross; Selcuk Onur Sumer; Bülent Arman Aksoy; Anders Jacobsen; Caitlin J Byrne; Michael L Heuer; Erik Larsson; Yevgeniy Antipin; Boris Reva; Arthur P Goldberg; Chris Sander; Nikolaus Schultz
Journal:  Cancer Discov       Date:  2012-05       Impact factor: 39.397

10.  ZBTB7A acts as a tumor suppressor through the transcriptional repression of glycolysis.

Authors:  Xue-Song Liu; Jenna E Haines; Elie K Mehanna; Matthew D Genet; Issam Ben-Sahra; John M Asara; Brendan D Manning; Zhi-Min Yuan
Journal:  Genes Dev       Date:  2014-09-01       Impact factor: 11.361

View more
  5 in total

1.  Heterogeneous microenvironment analysis to explore the potential regulatory role of endothelial-mesenchymal transition in idiopathic pulmonary fibrosis.

Authors:  Yinning Xu; Xiaoping Hu; Yiwen Zhang; Zongfu Pan; Zhiyong Sun; Zhongjie Huang; Shuilian Zheng; Hansheng Pan; Xiaozhou Zou; Ping Huang
Journal:  Ann Transl Med       Date:  2022-04

2.  Structural basis for human ZBTB7A action at the fetal globin promoter.

Authors:  Yang Yang; Ren Ren; Lana C Ly; John R Horton; Fudong Li; Kate G R Quinlan; Merlin Crossley; Yunyu Shi; Xiaodong Cheng
Journal:  Cell Rep       Date:  2021-09-28       Impact factor: 9.423

3.  ZBTB7A, a miR-144-3p targeted gene, accelerates bladder cancer progression via downregulating HIC1 expression.

Authors:  Junqiang Liu; Zhiyuan Chou; Chun Li; Kai Huang; Xuejian Wang; Xiunan Li; Chuanchun Han; Abdullah Al-Danakh; Xiaodong Li; Xishuang Song
Journal:  Cancer Cell Int       Date:  2022-05-02       Impact factor: 6.429

4.  Combining Recombinase-Mediated Cassette Exchange Strategy with Quantitative Proteomic and Phosphoproteomic Analyses to Inspect Intracellular Functions of the Tumor Suppressor Galectin-4 in Colorectal Cancer Cells.

Authors:  Malwina Michalak; Viola Golde; Dominik Helm; Herbert Kaltner; Johannes Gebert; Jürgen Kopitz
Journal:  Int J Mol Sci       Date:  2022-06-08       Impact factor: 6.208

5.  Protocols for protein-DNA binding analysis of a zinc finger transcription factor bound to its cognate promoter.

Authors:  Lana C Ly; Yang Yang; Fudong Li; Merlin Crossley; Yunyu Shi; Kate G R Quinlan
Journal:  STAR Protoc       Date:  2022-07-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.